• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Does pH-Balanced Vaginal Gel Improve Dyspareunia in Breast Cancer Survivors? 

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Dyspareunia and sexual dysfunction often occur in breast cancer survivors following adjuvant therapy
  • Vaginal gels can be used as treatment for dyspareunia
  • This study by Kim et al. (Obstetrics & Gynecology, 2017) sought to determine if pH-balanced vaginal gel using allayed the symptoms of dyspareunia in breast cancer survivors who were premenopausal at the time of diagnosis

METHODS:

  • Randomized Controlled Trial
  • Breast cancer survivors, who were diagnosed when they were premenopausal, and who experienced dyspareunia, were included in the study
    • 69 women were randomized to receive pH-balanced gel containing lactic acid
    • 67 women were randomized to receive a lactate-free placebo gel
  • The gel was applied 3 times weekly before bed, as well as before intercourse, for eight weeks

RESULTS:

  • Both groups demonstrated the following benefits although there were no differences between groups
    • Significant decrease in pain during intercourse
    • Significant improvement in overall Female Sexual Function Index score
    • Improvement in sexual dysfunction
  • In the pH-balanced group but not the placebo group:
    • Vaginal pH (indicator strip) decreased slightly (median from 6.5 to 5.5; P<.01)
    • Vaginal maturation index (sum of percentages of superficial cells, intermediate cells, and parabasal cells on smear) increased slightly (from 46.0 to 48.5; P<.01).
  • Neither group experienced severe adverse events

CONCLUSION:

  • pH-balanced vaginal gel is no better than a placebo gel for improving sexual function and dyspareunia in breast cancer survivors who were premenopausal at time of diagnosis

Learn More – Primary Sources:

Effect of a pH-Balanced Vaginal Gel on Dyspareunia and Sexual Function in Breast Cancer Survivors Who Were Premenopausal at Diagnosis: A Randomized Controlled Trial

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Practical info on sexual health for your women's healthcare practice
Dyspareunia – Is it a Diagnosis or a Description?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site